BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35781785)

  • 21. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.
    Benoit DD; Hoste EA; Depuydt PO; Offner FC; Lameire NH; Vandewoude KH; Dhondt AW; Noens LA; Decruyenaere JM
    Nephrol Dial Transplant; 2005 Mar; 20(3):552-8. PubMed ID: 15671075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
    Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
    PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
    Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
    Minoia C; Diella L; Perrone T; Loseto G; Pelligrino C; Attolico I; Pasciolla C; Totaro V; De Candia MS; Spada V; Clemente F; Camporeale M; Di Gennaro F; Guarini A; Musto P; Saracino A; Bavaro DF
    Br J Haematol; 2023 Sep; 202(5):928-936. PubMed ID: 37259629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.
    Kakavandi S; Hajikhani B; Azizi P; Aziziyan F; Nabi-Afjadi M; Farani MR; Zalpoor H; Azarian M; Saadi MI; Gharesi-Fard B; Terpos E; Zare I; Motamedifar M
    Cell Commun Signal; 2024 Feb; 22(1):126. PubMed ID: 38360719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic immunomodulatory agents in patients with cancer and COVID-19.
    Jee J; Stonestrom AJ; Devlin S; Nguyentran T; Wills B; Narendra V; Foote MB; Lumish M; Vardhana SA; Pastores SM; Korde N; Patel D; Horwitz S; Scordo M; Daniyan AF
    Sci Rep; 2021 Mar; 11(1):4814. PubMed ID: 33649382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
    Azzi JM; Kyvernitakis A; Shah DP; El Haddad L; Mahajan SN; Ghantoji SS; Heredia-Ariza E; Chemaly RF
    J Antimicrob Chemother; 2018 Nov; 73(11):3162-3169. PubMed ID: 30113677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
    Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
    Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
    DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
    Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
    Wang Q; Berger NA; Xu R
    Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
    Aiello TF; Puerta-Alcalde P; Chumbita M; Lopera C; Monzó P; Cortes A; Fernández-Avilés F; Suárez-Lledó M; Correa J; Ortiz-Maldonado V; Cuesta G; Martinez-Cibrian N; Esteve J; Marcos MÁ; Mensa J; Soriano A; Garcia-Vidal C
    J Antimicrob Chemother; 2023 Jun; 78(6):1454-1459. PubMed ID: 37051877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
    Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
    Bhogal T; Khan UT; Lee R; Stockdale A; Hesford C; Potti-Dhananjaya V; Jathanna A; Rahman S; Tivey A; Shotton R; Sundar R; Valerio C; Norouzi A; Walker P; Suckling R; Armstrong A; Brearton G; Pettitt A; Kalakonda N; Palmer DH; Jackson R; Turtle L; Palmieri C
    Leuk Lymphoma; 2021 Jul; 62(7):1682-1691. PubMed ID: 33508995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study.
    Mimura W; Fukuda H; Akazawa M
    Ann Clin Microbiol Antimicrob; 2020 Feb; 19(1):7. PubMed ID: 32066448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.